Group 1: Company Overview and Strategic Focus - Huaxi Biological Technology emphasizes synthetic biology as a key driver for bio-manufacturing, aligning with government initiatives to accelerate new productivity in 2024 [1][2] - The company aims to leverage synthetic biology to produce renewable and recyclable products, reducing environmental pollution and enhancing health benefits [2] - Huaxi's development logic focuses on transforming scientific research into technology and products, supported by a comprehensive R&D system covering the entire industry chain [2][3] Group 2: R&D and Innovation - The R&D team consists of core technical personnel with extensive experience, enabling full-chain coverage from raw materials to end products [2] - The company has established four main platforms for R&D: synthetic biology, fermentation process control, mechanism application research, and compound modification [2] - Over 20 substances have completed trial production, with nearly 20 more in pilot testing, including high-value materials essential for human health [3] Group 3: Market Strategy and Product Development - Huaxi focuses on two key areas: the development of hyaluronic acid and its derivatives, and six categories of life health substances [3] - The company has launched a new generation of micro-crosslinked products, enhancing its product matrix to meet diverse consumer needs [6] - The medical beauty sector has seen significant growth, driven by a customer-centric approach and a diverse product line that meets personalized demands [6][7] Group 4: Organizational Transformation and Efficiency - The company has undergone a comprehensive transformation since 2021, focusing on strategic alignment and performance management [4][5] - Over 500 management indicators have been redefined to enhance operational efficiency and align with strategic goals [5] - The transformation has led to a slight increase in profit margins and a reduction in expense ratios in the first quarter [5] Group 5: Financial Management and Cost Control - Huaxi is optimizing its supply chain cost accounting system to improve production capacity and inventory turnover [9] - A business-oriented financial analysis system has been established to support decision-making and assess expense efficiency [9] - The company is enhancing its financial organization by establishing a financial shared center to better control financial and operational risks [9]
华熙生物(688363) - 华熙生物投资者关系活动记录表(2024年6月28日)